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a b s t r a c t
Nowadays, ST elevation acute myocardial infarction (STEMI) is seen with greater incidence
in older patients. Current guidelines recommend an immediate invasive evaluation and
eventually primary percutaneous coronary intervention (PCI) in all STEMI patients regard-
less of age. Nevertheless, data in literature show a signiﬁcant underuse of interventional
treatment in older patients with STEMI.
Our objective is to assess the in-hospital outcome of the elderly STEMI patients compared
to the younger ones in the setting of systematic interventional management. We also
discussed some particular aspects which we considered as signiﬁcant concerning the
management of elderly patients with STEMI.
We evaluated 975 consecutive STEMI patients admitted to a single centre between
January 2012 to July 2013. There were 203 (20.8%) patients ≥75 years old.
Compared to the younger group, in the older group there were more women (47. 2% vs
22.7%; p < 0.001), an increased prevalence of hypertension (78.8% vs 65.0%; p < 0.001) but a
decreased prevalence of smoking (13.7% vs 48.8%; p < 0.001) and dyslipidemia (54.7% vs
41.3%; p = 0.03). The ≥75 years group had more cardiovascular comorbidities: stroke (11.8% vs
4.1%; p < 0.001), atrial ﬁbrillation (23.6% vs 53.9%; p < 0.001) and severe valvulopathies (6.8%
vs 1.2%; p < 0.001). Elderly patients presented more frequently with signs of heart failure
(Killip class > 1: 21.1% vs 7.2%; p < 0.001). Both groups had similar ischaemia time with 54.1%
vs 55.1% presenting within 6 h.
There were fewer PCIs performed in the elderly group (74.3% vs 85.7%; p = 0.02). The
extension of coronary lesions was not signiﬁcantly different between the two groups, except
for left main disease in favour of the elderly (12.2% vs 5.1%; p < 0.001). There were no
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for our entire study group was 4.41%, with a rate of 11.3% in the older group and 2.59% in the
<75 years group ( p < 0.001).
In-hospital outcome in older patients with STEMI is worse, with an increased mortality
rate, especially when associated with heart failure on admission. Fewer PCI were performed
in the older patients, although there was no difference in the pharmacological treatment. A
strategy based on urgent coronary angiography and, if necessary, primary PCI, should be
applied in all eligible patients irrespective of age.
# 2014 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp. z o.o.
All rights reserved.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 3 4 2 – e 3 4 7 e343
.ContentsMethods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 343
Conﬂict of interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 346
Funding body . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 346
Ethical statement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 346
References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 346Introduction
A recent World Health Organization (WHO) report identiﬁed
coronary heart disease (CHD) as the leading cause of death
worldwide [1]. Although mortality due to acute coronary
events decreased progressively especially in developed
countries [2] through improvement in the methods of
treatment, including secondary prevention, and modiﬁcation
of risk factors by lowering total cholesterol and blood pressure
and discouraging smoking and sedentary lifestyle [3], it
remains responsible for about a third of all deaths in
adulthood [4,5].
According to WHO, especially in the low to medium income
countries, the burden of cardiovascular disease is increasing
more rapidly due to population ageing [1]. Cardiovascular
morbidity and mortality rise rapidly with increasing age.
Patients older than 65 years account for 60% of myocardial
infarction-related  deaths [6]. Age is a well known risk factor for
adverse outcome after an acute coronary syndrome (ACS),
being a part of major algorithms for outcome prediction [7].
Recent data regarding the incidence of STEMI in the U.S.
population showed a reduction of STEMI compared to NSTEMI
incidence in elderly population. Analyzing the data between
2001 and 2010 from the Nationwide Inpatient Sample (NIS)
database, Khera et al. identiﬁed that a reduction of STEMI from
all types of myocardial infarction occurred in the elderly (over
80 years) from 42.8% in 2001 to 23.8% in 2010 [8]. Nevertheless,
the incidence remains high, due to the increasing number of
elderly patients. However, different data comes from ISACS-
TC registry (gathering information on ACS patients from 8
Eastern European transitional countries) [9]. In this registry the
proportion of STEMI among ACS patients was 59% compared
with 34.3% NSTEMI.
Considering these facts, the treatment of older patients
presenting with STEMI represents a signiﬁcant public health
issue due to the high number of cases, their complexity and
particularities.Methods
We studied retrospectively a cohort of 975 consecutive
patients with STEMI, admitted to our centre between January
2012 and July 2013. A total of 203 (20.8%) patients were ≥75
years old. The patients were followed during index hospital
admission for STEMI. The data were extracted from the
National STEMI Database of Romania, an observational
registry with demographics, practice patterns and health
outcomes.
Baseline characteristics, treatment and outcome for each
patient were gathered from their admission notes and
evaluated. We assessed the clinical risk factors: age, smoking,
arterial hypertension, dyslipidemia and diabetes mellitus, and
also the signiﬁcant cardiovascular comorbidities: previous MI
or PCI, atrial ﬁbrillation, history of stroke and severe
valvulopathies. The admission diagnosis of STEMI was made
according to the current ESC guidelines [10]. The clinical
presentation symptom was deﬁned as the major complaint of
the patient suggestive for ischaemia. We deﬁned the total
ischaemia time as the time from the symptom onset to the ﬁrst
balloon inﬂation. The primary endpoint was the in-hospital
mortality rate.
Cases of binary variables were counted and divided
according to age (≥75/<75 years old); analysis was performed
using the Chi-square test for one variable (with Yates
correction). Continuous variables were ﬁrst F-tested, resulting
in unequal variances; analysis was therefore performed using
Welch's independent two-sample two-tailed T-test for hetero-
scedastic data and samples of unequal size, with a level of
signiﬁcance of <0.05 for both.
Results
Our study population consists of 975 patients, 203 of which
are over 75 years old. The median age of the older group is
Table 1 – Comparison between older (≥75 years) and
younger patients (<75 years) groups.
<75 (n = 772) ≥75 (n = 203) p
Age, m (IQR) 56.9 (53–72) 80.6 (76–83) <0.001
Female, n (%) 176 (22.7%) 96 (47.2%) <0.001
Smokers, n (%) 377 (48.8%) 28 (13.7%) <0.001
AHT, n (%) 502 (65.0%) 160 (78.8%) 0.01
Dyslipidemia, n (%) 423 (54.7%) 84 (41.3%) 0.03
DM, n (%) 200 (25.9%) 43 (21.1%) 0.28
Stroke, n (%) 32 (4.1%) 24 (11.8%) <0.001
Previous MI, n (%) 77 (9.9%) 19 (9.3%) 0.82
Severe valvulopathy,
n (%)
10 (1.2%) 14 (6.8%) <0.001
Atrial ﬁbrilation, n (%) 46 (5.9%) 48 (23.6%) <0.001
Presentation
HR > 100 bpm, n (%) 123 (15.9%) 40 (19.7%) 0.19
SBP < 100 mmHg, n (%) 77 (9.9%) 22 (10.8%) 0.68
Anterior MI, n (%) 360 (46.6%) 106 (52.2%) 0.33
Killip class >1, n (%) 56 (7.2%) 43 (21.1%) <0.001
Presentation time
<6 h, n (%) 426 (55.1%) 110 (54.1%) 0.86
In-hospital management
ASA, n (%) 763 (98.8%) 191 (94.0%) 0.54
P2Y12 inhibitors, n (%) 760 (98.4%) 199 (98.0%) 0.91
Anticoagulation, n (%) 756 (97.9%) 197 (97.0%) 0.85
Beta-blocker, n (%) 714 (92.4%) 165 (81.2%) 0.13
ACEI/ARB, n (%) 713 (92.3%) 171 (84.2%) 0.27
Statin, n (%) 752 (97.4%) 189 (93.1%) 0.53
Coronary angiogram,
n (%)
744 (96.3%) 171 (84.3%) 0.10
PCI, n (%) 662 (85.7%) 151 (74.3%) 0.02
Outcome
Lowest LVEF, m (%) (IQR) 43.0 (38–48) 34.7 (30–40) <0.001
In-hospital death, n (%) 20 (2.59%) 23 (11.3%) <0.001
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(Table 1). The oldest patient was 97 years old. There were more
women in the older group (47.2% vs 22.7%; p < 0.001) and fewer
smokers (13.7% vs 48.8%; p < 0.001). There were more
hypertensives (78.8% vs 65.0%; p = 0.01) but less patients with
dyslipidemia (41.3% vs 54.7%; p = 0.03) and a trend for less
diabetics. The older group had more comorbidities, with more
patients having atrial ﬁbrillation (23.6% vs 5.9%; p < 0.001),
severe valvulopathies (6.8% vs 1.2%; p < 0.001) and history of
stroke (11.8% vs 4.1%; p < 0.001). There was no signiﬁcant
difference in the history of myocardial infarction.
In both groups, chest pain was the main symptom at
presentation (78.2% vs 76.0%; p = NS). However, shortness of
breath was signiﬁcantly more prevalent in the older group
(16.1% vs 6.3%; p < 0.001) and the heart failure expressed by >1
Killip functional class was more frequent (21.1% vs 7.2%;
p < 0.001). There was no difference in heart rate at presenta-
tion and a nonsigniﬁcant trend towards older patients
presenting with tachycardia (19.7% vs 15.9%; p = 0.19). There
were more patients with anterior myocardial infarction in the
elderly group (52.2% vs 46.6%; p = 0.33). Cardiogenic shock was
found in 2.9% in the elderly and 0.7% in the younger group.
Surprisingly, there was no difference regarding the total
ischaemic time with more than half of each group having
an ischaemic time of less than 6 h (54.1% vs 55.1%; p = NS).In a subgroup analysis, the elderly female group smoked
less (8.3% vs 20%), were more hypertensives (85.4% vs 76.2%),
had more DM (22.9% vs 18.8%) and dyslipidemia (48.9% vs
35.6%). At admission the females had a higher average HR
(84 bpm vs 76 bpm) and a lower systolic BP (96 mmHg vs
131 mmHg; p < 0.05).
There was a trend towards fewer patients ≥75 years
receiving a coronary angiogram for the index event (84.3%
vs 96.3%; p = 0.10) but also they underwent signiﬁcantly fewer
percutaneous revascularizations (74.3% vs 85.7%; p = 0.02).
There was a nonsigniﬁcant difference regarding the vascular
approach with radial approach being chosen in 28.2% in the
elderly vs 30.4% in the younger group ( p = NS). The extension
of coronary lesions (single-, bi-, tri-vessel disease) was not
signiﬁcantly different between the two groups, except for left
main disease in favour of the elderly (12.2% vs 5.1%; p < 0.001).
There was a nonsigniﬁcant difference concerning the in-
hospital medical treatment of the two groups with similar
rates of double antiplatelet treatment and anticoagulation.
Overall, the in-hospital mortality for our entire study group
was 4.41%, with a rate of 2.59% in the <75 years group and
11.3% in the older group ( p < 0.001). In a subgroup analysis we
found that females had a higher mortality both in the elderly
group (15% vs 7.7%) and in the younger group (3.49% vs 2.34%;
p < 0.05).
Discussion
Our study deals with the treatment strategy and outcome of
unselected STEMI patients in a high-volume primary PCI
centre, with an emphasis on a high-risk subgroup that consists
of patients over 75 years of age. It represents the ﬁrst study of
its kind in our country since the introduction of systematic
primary PCI treatment of STEMI.
Traditional risk factors for coronary artery disease de-
scribed in younger patients are also found in elderly patients.
However, their prevalence depends on the population studied.
Our population proﬁle is similar to the risk factor proﬁle of
other registry populations. Generally, registry patients tend to
be older and to have more risk factors compared to trial
patients. This was demonstrated when data from several
STEMI trials grouped in Virtual Coordinating Center for Global
Collaborative Cardiovascular Research (VIGOUR) were com-
pared to GRACE and NRMI registry populations [11]. Patients
above 75 years represented 14% of the entire trials population,
compared to 28% in the registry population. Furthermore,
registry patients were more frequently hypertensive (57.2% vs
48.3%), diabetic (28.1% vs 18.4%) and had more often a history
of cerebrovascular disease (10.7% vs 3.37%).
In elderly patients with acute coronary syndrome, clinical
presentation can vary signiﬁcantly. A recent study [12] which
included 255 STEMI patients ≥ 75 years old analyzed the
symptoms of presentation to the emergency room. It showed
that 41% of patients presented with chest pain, 15.7% pre-
syncope or syncope, 15.7% had dyspnoea, 9.8% had gastroin-
testinal symptoms, 6.7% had malaise and 5.0% had delirium.
Compared with those who had chest pain as ﬁrst clinical
complaint, patients with atypical clinical presentation had a
longer time from symptom onset to the admission, had
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10.5%, for atypical symptoms vs chest pain, respectively),
received less reperfusion therapy (40.7% vs 77.1%), and had a
higher mortality rate at one month (42.7% vs 21.0%).
There is little data on the reperfusion therapy for elderly
population with STEMI. The available data on elderly patients
with STEMI comes from subanalysis of major STEMI trials (in
which the elderly are often excluded either because of age
itself or due to associated pathologies which are more frequent
and/or more severe in this group) or from national registries
[6].
Present STEMI guidelines [10,13] support timely reperfusion
either interventional with primary PCI or pharmacological
(systemic thrombolysis) in patients presenting <12 h after
symptoms onset. No special remark is made concerning the
elderly. Rapid reperfusion is mandatory for a favourable
therapeutic outcome.
However, in elderly patients, reperfusion therapy is used to
lesser extent compared to younger patients. Ancillary data
from GRACE registry (2002) showed that almost one third of
STEMI patients presenting within 12 h from symptom onset
did not receive any reperfusion therapy [14]. The authors
identiﬁed age >75 years as an independent predictor associ-
ated with failure to receive reperfusion therapy (OR 2.63; 95%
CI, 2.04–3.38). The underuse of reperfusion in elderly is also
mentioned in a recent paper (2013) derived from the Belgian
STEMI Registry [15]. In our study, there was also an underuse of
invasive therapy explained by severe comorbidities, poor
general status and in a lesser manner by the delayed time to
presentation or diagnosis.
Patients with STEMI and shock represent a speciﬁc subset
due to the high rate of mortality which is hardly inﬂuenced by
reperfusion [16]. Current guidelines give class I indication for
invasive strategy with the aim of early reperfusion in patients
with STEMI and cardiogenic shock irrespective of age [10,13]. It
is also recommended that in patients with cardiogenic shock
due to pump failure, percutaneous treatment of a severe
stenosis in a large noninfarct artery might be considered
during primary PCI.
In the only randomized trial performed in patients with
shock (SHOCK trial), there was a non-signiﬁcant trend
towards a worse outcome in the subgroup of elderly patients
(>75 years) treated with an invasive approach [17]. This
trend was opposed to the signiﬁcant survival beneﬁt with
invasive approach that was demonstrated in this trial for the
whole study group. However, the beneﬁts of an invasive
management in elderly patients with shock complicating
STEMI were proven by several registries including the most
recent registry report coming from the Korea Acute
Myocardial Infarction Registry (KAMIR) [18]. In-hospital
mortality rate for the 366 elderly patients (>75 years old)
with shock treated between 2008 and 2011 favoured an
invasive approach (46.4% conservative vs 23.5% invasive;
p < 0.001).
In light of these results, an invasive approach should not be
denied to elderly patients with STEMI and cardiogenic shock.
The advantages of invasive approach observed in registry
based data might be determined by selecting only those
patients considered eligible for this therapy according to the
judgement of the treating physician. As a consequence, themanagement of elderly patients with STEMI and cardiogenic
shock should be decided after a careful evaluation of the
patient in terms of previous comorbidities, functional status
and even life expectancy.
From the technical point of view, in older patients there is
an increased prevalence of vascular tortuosity and peripheral
artery disease, multivessel coronary involvement, along with a
higher incidence of complex lesions, small diameter arteries,
calciﬁed lesions, and diffuse disease, making fast and effective
reperfusion a challenging target.
Radial approach, which was associated with a decreased
incidence of bleeding complications at the access site, rapid
mobilization, improved patient comfort [19], and a lower
mortality in patients with STEMI is currently used more
frequently. Traditionally, the radial approach was limited in
elderly patients due to fear of vascular fragility, comorbidities
and technical difﬁculties determined by a higher incidence of
vascular tortuosity. In our study group, the decision regarding
the vascular approach was made solely on physician'
judgement and preference.
There are three major studies which have shown the
feasibility and beneﬁt of the radial approach in patients with
acute coronary syndrome: RIVAL, RIFLE – STEACS and STEMI –
RADIAL [20–22]. Compared with the femoral approach in
patients with STEMI, the radial approach has been shown to be
associated with signiﬁcantly lower rates of cardiac death (5.2%
vs 9.2%; p = 0.020), bleeding (7.8% vs 12.2%; p = 0.026) and
hospital stay [21].
Another issue associated with radial approach is whether
this approach was associated with a delay in providing
reperfusion. Secco et al. [23] analyzed the data of 283
consecutive patients with STEMI > 75 years, treated with
primary PCI which was carried through radial approach in 177
cases and through femoral approach in 106 cases. In this
series, radial approach in elderly patients was not associated
with an increase in door-to-balloon time. Thus, he demon-
strated the feasibility and effectiveness of this approach in
elderly patients with STEMI.
Freixa et al. [24] analyzed the beneﬁt of left radial approach
in octogenarians without history of CABG. Patients were
randomized 1:1 to left versus right radial approach, having the
procedure time and ﬂuoroscopy time as primary endpoints.
Subclavian artery tortuosity was more frequent with the right
approach, but this difference did not result into a higher cross-
over rate and procedure or ﬂuoroscopy time. The study
concluded that the left radial approach is a valid method in
octogenarians and that it was not associated with beneﬁts in
terms of procedure or ﬂuoroscopy time.
As a consequence, recent registry data from 2013, from
France indicated an increase in radial artery access usage in
elderly patients with STEMI from 60% in 2010 to almost 80% in
2012 [25].
A signiﬁcantly underused predictor of adverse events in old
patients with acute coronary syndromes is frailty. Frailty is a
common geriatric syndrome related to adverse outcomes in
older patients. It can be deﬁned as a physiological state of low
biological reserve which results in increased vulnerability to
stressors [26]. Acute coronary syndromes represent a signiﬁ-
cant stress, and elderly patients may often respond in an
unpredictable manner. When exposed to stress, the 'fragile
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complications, proloanged recovery, functional decline, all of
which may result in disability or even death. Although a
consensus deﬁnition and corresponding assessment tool does
not exist yet [27], a widely used operational phenotype for
frailty includes 5 criteria: exhaustion, weight loss, low physical
activity, weak hand grip, and slow gait speed [28], known as the
Fried score.
In a study that included 309 elderly patients hospitalized in
a coronary care unit due to multivessel coronary artery
disease, Purser et al. showed that frailty varies considerably
depending on the assessment tool used: 27% on the Fried
scale, 50% on walking speed < 0.65 m/s, and 63% on the
Rockwood scale [29]. However, only walking speed was
signiﬁcantly associated with an increased 6 months mortality
(OR 4.0).
Frailty was also studied in the setting of revascularization
procedures. In one study that included 629 elderly patients
undergoing PCI at the Mayo Clinic, the prevalence of frailty was
21% as assessed by the Fried scale before discharge, being
associated with a signiﬁcant increase in mortality at 3 years
(28% vs 6%, OR 2.74) [30].
Conclusions
Elderly STEMI patients represented almost a ﬁfth of the STEMI
patients treated consecutively in our centre and presented
with a signiﬁcantly higher in-hospital mortality compared to
the rest of the patients.
A strategy based on urgent coronary angiography and PCI in
the infarct related artery should be performed in all eligible
patients irrespective of age. The expected beneﬁt is bigger in
higher risk patients.
Radial approach for primary PCI is a feasible approach,
provided that the treating physician is experienced with this
technique.
Speciﬁc geriatric assessment such as frailty evaluation
should be included in cardiovascular risk assessment in the
elderly, in order to reﬁne the outcome prediction as advanced
chronological age and other classical risk factors do not always
provide an accurate reﬂection of the health status. Speciﬁc
scoring systems which integrate the severity of coronary
disease, the presence of comorbidities which may increase the
risk of different therapeutic approaches and parameters that
reﬂect the 'functional' rather than the chronological age may
be needed for adequate tailoring of the therapy. In our study,
we did not evaluate patients based on objective scoring
systems and we based our therapeutic decisions solely on
physician's judgement.
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